Trials / Recruiting
RecruitingNCT06273436
Healing, Equity, Advocacy and Respect for Mamas
Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,894 (estimated)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- Female
- Age
- 16 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.
Detailed description
The purpose of the study is to learn if a program for newborn mom's can improve detection of complications after delivery and help women get medical care quickly and easily. Participants will be asked to complete a survey at the time of enrollment and at 3 additional times. All surveys can be completed via cell-phone or email. All women will be followed for 1-year after delivery. Women that enroll will be assigned to one of two groups: usual in person care OR usual in-person care PLUS a text message-based program that will ask about sign and symptoms of complications that may occur after delivery. If there is a concern, a nurse advocate will call on the phone to discuss options and help refer to care if needed. Participants will be paid for their time in completing surveys.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | H.E.A.R. for Mamas | H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings. |
Timeline
- Start date
- 2024-05-28
- Primary completion
- 2028-11-30
- Completion
- 2030-03-30
- First posted
- 2024-02-22
- Last updated
- 2026-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06273436. Inclusion in this directory is not an endorsement.